Seeking Alpha

BIND
  BIND Therapeutics, Inc. - NASDAQ

11/26/2014, 3:52 AM ET
52wk high:  
52wk low:  
EPS:  
PE (ttm):  
Div Rate:  
Yield:  
Market Cap:  
Volume:  
BIND vs. ETF Alternatives
Company Description
Bind Therapeutics Inc is a clinical-stage nanomedicine platform company developing Accurins, its novel targeted and programmable therapeutics.
Sector: Healthcare
Industry: Biotechnology
Country: United States